90 related articles for article (PubMed ID: 7659302)
21. CCK is involved in both peripheral and central mechanisms controlling food intake in chickens.
Rodríguez-Sinovas A; Fernández E; Manteca X; Fernández AG; Goñalons E
Am J Physiol; 1997 Jan; 272(1 Pt 2):R334-40. PubMed ID: 9039026
[TBL] [Abstract][Full Text] [Related]
22. The antagonistic effect of cholecystokinin octapeptide (CCK-8) on opioid effects in cardiovascular activities was mediated by CCK-B receptor.
Mei L; Han JS
Sci China B; 1993 Jul; 36(7):817-23. PubMed ID: 8216742
[TBL] [Abstract][Full Text] [Related]
23. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
Minabe Y; Ashby CR; Wang RY
Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
[TBL] [Abstract][Full Text] [Related]
24. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.
Ge J; Long SK; Kilpatrick IC
Eur J Pharmacol; 1998 Mar; 345(2):163-70. PubMed ID: 9600632
[TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin B-type receptors mediate a G-protein-dependent depolarizing action of sulphated cholecystokinin ocatapeptide (CCK-8s) on rodent neonatal spinal ventral horn neurons.
Oz M; Yang KH; Shippenberg TS; Renaud LP; O'Donovan MJ
J Neurophysiol; 2007 Sep; 98(3):1108-14. PubMed ID: 17581850
[TBL] [Abstract][Full Text] [Related]
26. Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide.
Hernando F; Fuentes JA; Ruiz-Gayo M
Br J Pharmacol; 1996 May; 118(2):400-6. PubMed ID: 8735644
[TBL] [Abstract][Full Text] [Related]
27. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
28. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
Zavros Y; Shulkes A
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
[TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity.
Akaike A; Tamura Y; Sato Y; Ozaki K; Matsuoka R; Miura S; Yoshinaga T
Brain Res; 1991 Aug; 557(1-2):303-7. PubMed ID: 1684128
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor-1 attenuates apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats.
Tagami M; Ikeda K; Nara Y; Fujino H; Kubota A; Numano F; Yamori Y
Lab Invest; 1997 May; 76(5):613-7. PubMed ID: 9166280
[TBL] [Abstract][Full Text] [Related]
32. CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors.
Karlsson S; Ahrén B
Eur J Pharmacol; 1992 Mar; 213(1):145-6. PubMed ID: 1499651
[TBL] [Abstract][Full Text] [Related]
33. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
Kelland MD; Zhang J; Chiodo LA; Freeman AS
Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
[TBL] [Abstract][Full Text] [Related]
34. Functional role of brain CCK receptors.
Woodruff GN; Hill DR; Boden P; Pinnock R; Singh L; Hughes J
Neuropeptides; 1991 Jul; 19 Suppl():45-56. PubMed ID: 1881532
[No Abstract] [Full Text] [Related]
35. Cholecystokinin evokes secretion of oxytocin and vasopressin from rat neural lobe independent of external calcium.
Bondy CA; Jensen RT; Brady LS; Gainer H
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5198-201. PubMed ID: 2740351
[TBL] [Abstract][Full Text] [Related]
36. Role of substance P in the regulation of ion transport by CCKA and CCKB receptors in mouse ileum.
Rao RK; Levenson S; Fang SN; Hruby VJ; Yamamura HI; Porreca F
Ann N Y Acad Sci; 1994 Mar; 713():420-1. PubMed ID: 7514373
[No Abstract] [Full Text] [Related]
37. Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats.
Blandizzi C; Natale G; Carignani D; Colucci R; Lazzeri G; Del Tacca M
Neurosci Lett; 1995 Jun; 193(1):13-6. PubMed ID: 7566655
[TBL] [Abstract][Full Text] [Related]
38. Changes in extracellular concentration of amino acids in the hippocampus during cerebral ischemia in stroke-prone SHR, stroke-resistant SHR and normotensive rats.
Gemba T; Matsunaga K; Ueda M
Neurosci Lett; 1992 Feb; 135(2):184-8. PubMed ID: 1625792
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation.
Smith AJ; Patel S; Freedman SB
Eur J Pharmacol; 1994 Apr; 267(2):215-23. PubMed ID: 8050481
[TBL] [Abstract][Full Text] [Related]
40. Vitamin E prevents apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats.
Tagami M; Ikeda K; Yamagata K; Nara Y; Fujino H; Kubota A; Numano F; Yamori Y
Lab Invest; 1999 May; 79(5):609-15. PubMed ID: 10334572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
